HOME >> MEDICINE >> NEWS
Crohn's & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases

Global publisher John Wiley & Sons, Inc., announced today that it has been selected by the Crohn's & Colitis Foundation of America (CCFA) as the new publisher of the Foundation's official journal, Inflammatory Bowel Diseases, effective January 2007.

Inflammatory Bowel Diseases is the first and only peer-reviewed journal dedicated exclusively to inflammatory bowel diseases. Now in its tenth year, the journal provides articles of interest to professionals treating patients and conducting research in this expanding field. Each issue contains articles on clinical and basic science, as well as reviews of treatments and ground-breaking research.

"This is a wonderful partnership opportunity for Wiley," said Shawn Morton, Wiley Vice President and Publishing Director, Medicine. "We look forward to facilitating communication about the mechanisms and treatment of Crohn's disease and ulcerative colitis through this premier publication in collaboration with CCFA."

Wiley will begin publishing the journal in 2007 and will continue to make it available in print and online as a benefit of CCFA Professional Membership, and through subscription to other individual and institutional customers. Inflammatory Bowel Diseases will be available online via Wiley InterScience (www.interscience.wiley.com), the company's online publishing platform.

"CCFA is extremely proud of this journal, which provides an important forum for the best and the brightest scientists and clinicians in our field to report on the advances that are being made," said Jonathan Braun, M.D., Ph.D., Professor, David Geffen School of Medicine, UCLA Medical Center, and Chair of CCFA's National Scientific Advisory Committee. "We're confident that our partnership with Wiley will allow us to build on the journal's success, and expand our outreach to the medical community."


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
20-Mar-2006


Page: 1

Related medicine news :

1. ECP may be effective in treating Crohns disease
2. Smoking influences Crohns disease
3. Researchers identify new therapy for patients with Crohns disease
4. Canada high in ulcerative colitis and Crohns cases: Is Canada too clean?
5. Penn State research shows withdrawal drug offers relief for Crohns sufferers
6. Immune signals of variations of a single gene linked to more severe Crohns disease
7. Biologic therapies lead evolution of Crohns treatments
8. FDA grants priority review of Remicade® for children with Crohns disease
9. New insight into cause of Crohns disease
10. Improved diagnostic technology for Crohns disease
11. UVa Health System wins renewal of $6.2 million grant for Crohns disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to meet talent shortages ... outdated healthcare executive resume. , “If you’re a healthcare executive open to new opportunities ... if it’s as ready as you are for a new job search. I’ve heard ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology:
Cached News: